Report Detail

Request for Sample of this report

Pharma & Healthcare Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3854030
    • |
  • 18 December, 2019
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Description

Scope of the Report:
The worldwide market for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Eli Lilly
Boehringer Ingelheim
Janssen Pharmaceuticals
Kotobuki Pharmaceutical
Astellas
Bristol Myers Squibb
AstraZeneca

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Invokana (Canagliflozin)
Jardiance (Empagliflozin)
Farxiga/Forxiga (Dapagliflozin)
Suglat (Ipragliflozin)

Market Segment by Applications, can be divided into
Hospital
Medical Research Institute
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors, with price, sales, revenue and global market share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in 2017 and 2018.
Chapter 3, the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Invokana (Canagliflozin)
      • 1.2.2 Jardiance (Empagliflozin)
      • 1.2.3 Farxiga/Forxiga (Dapagliflozin)
      • 1.2.4 Suglat (Ipragliflozin)
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital
      • 1.3.2 Medical Research Institute
      • 1.3.3 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Eli Lilly
      • 2.1.1 Business Overview
      • 2.1.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Boehringer Ingelheim
      • 2.2.1 Business Overview
      • 2.2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Janssen Pharmaceuticals
      • 2.3.1 Business Overview
      • 2.3.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Kotobuki Pharmaceutical
      • 2.4.1 Business Overview
      • 2.4.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Astellas
      • 2.5.1 Business Overview
      • 2.5.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Bristol Myers Squibb
      • 2.6.1 Business Overview
      • 2.6.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 AstraZeneca
      • 2.7.1 Business Overview
      • 2.7.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis by Regions

    • 4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 4.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 4.5 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)

    5 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country

    • 5.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Market Share by Country
      • 5.1.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 5.3 Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)

    6 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country

    • 6.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 6.3 UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 6.4 France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 6.5 Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 6.6 Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country

    • 7.1 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Country (2014-2019)
    • 7.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 7.3 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 7.4 Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 7.5 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)

    8 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country

    • 8.1 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Market Share by Country
      • 8.1.1 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Countries

    • 9.1 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Growth Rate (2014-2019)

    10 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment by Type

    • 10.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Type (2014-2019)
    • 10.2 Invokana (Canagliflozin) Sales Growth and Price
      • 10.2.1 Global Invokana (Canagliflozin) Sales Growth (2014-2019)
      • 10.2.2 Global Invokana (Canagliflozin) Price (2014-2019)
    • 10.3 Jardiance (Empagliflozin) Sales Growth and Price
      • 10.3.1 Global Jardiance (Empagliflozin) Sales Growth (2014-2019)
      • 10.3.2 Global Jardiance (Empagliflozin) Price (2014-2019)
    • 10.4 Farxiga/Forxiga (Dapagliflozin) Sales Growth and Price
      • 10.4.1 Global Farxiga/Forxiga (Dapagliflozin) Sales Growth (2014-2019)
      • 10.4.2 Global Farxiga/Forxiga (Dapagliflozin) Price (2014-2019)
    • 10.5 Suglat (Ipragliflozin) Sales Growth and Price
      • 10.5.1 Global Suglat (Ipragliflozin) Sales Growth (2014-2019)
      • 10.5.2 Global Suglat (Ipragliflozin) Price (2014-2019)

    11 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment by Application

    • 11.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Sales Growth (2014-2019)
    • 11.3 Medical Research Institute Sales Growth (2014-2019)
    • 11.4 Other Sales Growth (2014-2019)

    12 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2019-2024)

    • 12.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2019-2024)
      • 12.2.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2019-2024)
      • 12.2.4 South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast (2019-2024)
    • 12.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast by Type (2019-2024)
      • 12.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share Forecast by Type (2019-2024)
    • 12.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Forecast by Application (2019-2024)
      • 12.4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors. Industry analysis & Market Report on Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors is a syndicated market report, published as Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,690.04
      		4,035.06
      		5,380.08
      		3,239.88
      		4,859.82
      		6,479.76
      		531,361.20
      		797,041.80
      		1,062,722.40
      		293,712.00
      		440,568.00
      		587,424.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo